Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccinations targeting the spike protein (S) offer protective immunity against coronavirus disease 2019 (COVID-19). This immunity may further be shaped by cross-reactivity with common cold coronaviruses. Mutations arisi...
Main Authors: | Muriel Aguilar-Bretones, Ron A.M. Fouchier, Marion P.G. Koopmans, Gijsbert P. van Nierop |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-01-01
|
Series: | The Journal of Clinical Investigation |
Online Access: | https://doi.org/10.1172/JCI162192 |
Similar Items
-
SARS-CoV-2 vaccination in the context of original antigenic sin
by: Marek Petráš, et al.
Published: (2022-01-01) -
Original Antigenic Sin on Antibody Response in SARS-CoV-2 Infection
by: Miao Wang, et al.
Published: (2024-07-01) -
The “original antigenic sin” and its relevance for SARS-CoV-2 (COVID-19) vaccination
by: Ger T. Rijkers, et al.
Published: (2021-12-01) -
Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS
by: Walter Fierz, et al.
Published: (2020-06-01) -
Original antigenic sin in dengue - Hoskins effect
by: Vasantha Kamath, et al.
Published: (2023-01-01)